Score Your Stock

CENGILD CENGILD MEDICAL BERHAD

0243.KL · Health Care · Health Care Providers
Bottom 48% of scored stocks
Compare with nearby peers
OkayBottom 48% of scored stocksLast year (FY2025): 57
Shariah

CENGILD scores 48/100 on fundamentals: in the bottom 48% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (83/100); its weakest is Risk (33/100).

Best
Financial 83
Weakest
Risk 33
Mkt capRM 133.3m#637 of 1113 in BursaEPSRM 0.01P/E11.7×✓ vs sector avg 26.9×P/B1.1×✓ vs sector avg 1.8×Div yield2%✓ Top 39% in Bursa52w range · 25% of range0.130.25
as of 18 Oct 2026

Nearby peers

Ranks #17 of 30 in Health Care by score

#1DPHARMA85#15OPTIMAX50#16UMC50
#17CENGILD48
#18TOPVISN44#19LACMED44

One-Minute Summary

Why CENGILD scores 48

A financially strong, inexpensively priced stock, but risk needs attention.

What looks good
What to watch

After Jun '26 results: 51 → 54+3· P/E Ratio Okay → StrongSee all movers →

Business Strength

40
Why 40?
Pillar score: (1 + 1 + 0 + 2 + 0) = 4 of 10 points → 40
Return on Equity (ROE)10%Okay4-Year Revenue Growth+1%/yrOkay4-Year Profit Growth-5%/yrWeakNet Profit Margin16%StrongQuarterly Momentum-9%Weak
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -14.3%Equity ↑ +13.1%ROE % 9.5%
Net ProfitEquityROE %
13m11m11m11m106m111m115m120m202320242025202612.5%10%9.7%9.5%

Revenue & Net Profit, with Net Margin

Revenue ↑ +4.1%Net Profit ↓ -14.3%Net Margin % 15.6%
RevenueNet ProfitNet Margin %
70m67m80m73m13m11m11m11m202320242025202618.9%16.6%13.9%15.6%

Sales have been roughly flat for 4 years: the business isn't really growing, just maintaining.

Profit fell about 14.3% from where it was 4 years ago: the boom has cooled off.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↓ -12.6%Net Profit ↑ +5%Net Margin % 21.5%
RevenueNet ProfitNet Margin %
22m20m18m20m19m19m17m20m4m3m2m2m3m3m2m4mSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '2617.9%14.4%10.4%11.3%15.5%14.6%9.7%21.5%
▲▬▼▲▼▼▼▲

Sales fell about 12.6% over the last 8 quarters: worth watching why.

Profit has moved sideways over the last 8 quarters.

Why 83?
Pillar score: (1 + 2 + 2) = 5 of 6 points → 83
Debt-to-Equity0.7×OkayCurrent Ratio3.2×StrongInterest Coverage75.3×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +476.5%Equity ↑ +13.1%D/E 0.7×
Total DebtEquityD/E
15m8m48m86m106m111m115m120m20232024202520260.1×0.1×0.4×0.7×

Borrowings grew about 476.5% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↓ -41%Current Liabilities ↑ +72.8%Current Ratio 3.2×
Current AssetsCurrent LiabilitiesCurrent Ratio
106m99m98m63m11m15m20m20m20232024202520269.3×6.7×4.9×3.2×
Why 38?
Pillar score: (0 + 1 + 0 + 2) = 3 of 8 points → 38
Dividend Quality2%Weak
Payout ratio: 51%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowNegative recentlyWeakCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -5.8%Free CF ↓ -678%
Operating CFFree CF
14m13m16m13m12m-3m-21m-68m2023202420252026

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↑ +825%Total Debt ↑ +476.5%
CashTotal Debt
1m2m12m7m15m8m48m86m2023202420252026

Dividends per Share, with Yield

DPS (sen) ↑ +162.2%Yield % 1.8%
DPS (sen)Yield %
0.40.70.7120222023202420250.9%2%2.7%1.8%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 50?
Pillar score: (2 + 1 + 0) = 3 of 6 points → 50
P/E Ratio11.7×StrongP/B Ratio1.1×OkayPEG Ration/m (growth not measurable)Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 0.24RM 0.20RM 0.16100500score 57 → 48Oct '25Feb '26Jun '26Oct '26💰💰

The share price is down about 29.2% over the past year.

What happened, and how the price moved

  • 11 Sep 2026Ex-dividend 0.03 sen a share0.1% yield at that priceWeek0.0%KLCI −1.3%Month0.0%KLCI −4.5%
  • 25 Feb 2026Ex-dividend 0.33 sen a share1.5% yield at that priceWeek▲1.8%KLCI −2.1%Month▲1.8%KLCI −1.8%
Why 33?
Pillar score: (2 + 0 + 2 + 0 + 0 + 0) = 4 of 12 points → 33
Earnings ConsistencySteadyStrongDebt Trend (4yr)RisingWeakShare Count Trend (4yr)+0%/yrStrongInventory vs Sales (4yr)+22.5 pp/yr vs salesWeakAsset Turnover Trend (4yr)-38.7%WeakQuarterly Consistency3 of 4 quarters downWeak
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +4.1%Inventory ↑ +85.7%Inv. % of Rev. 3.6%
RevenueInventoryInv. % of Rev.
70m67m80m73m1m2m2m3m20232024202520262%2.5%2.5%3.6%

Get an email when CENGILD's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #17 of 30 in Health Care by score

Sector peers

#1DPHARMA85#15OPTIMAX50#16UMC50
#17CENGILD (you)48
#18TOPVISN44#19LACMED44

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026RM 73.2mRM 11.4mRM 13.1mRM -68.2mRM -81.3mRM 7.4mRM 85.9mRM 120.0mRM 62.7mRM 19.7mRM 224.0mRM 104.0mRM 2.6m-10%16%0.7×3.2×75.3×51%2%14.2×1.4×-
2025RM 80.0mRM 11.1mRM 16.1mRM -21.2mRM -37.3mRM 11.8mRM 47.5mRM 114.5mRM 98.4mRM 20.1mRM 180.5mRM 66.0mRM 2.0mRM 1.0m10%14%0.4×4.9×47.7×73%4%16.8×1.6×3.0
2024RM 66.8mRM 11.1mRM 12.9mRM -2.8mRM -15.7mRM 1.9mRM 8.1mRM 111.3mRM 99.4mRM 14.8mRM 132.4mRM 21.1mRM 1.7mRM 0.7m10%17%0.1×6.7×28.8×56%3%22.2×2.2×2.6
2023RM 70.3mRM 13.3mRM 13.9mRM 11.8mRM -2.1mRM 0.8mRM 14.9mRM 106.1mRM 106.2mRM 11.4mRM 131.7mRM 25.6mRM 1.4mRM 0.7m13%19%0.1×9.3×24.7×46%2%22.6×2.8×0.6